Accelerating the iMpact of microsurgEry by upscaling production of thE world’s f...
Accelerating the iMpact of microsurgEry by upscaling production of thE world’s first microsurgical roboT: MUSA
The revolution in microsurgery is here. Microsure, a highly innovative Dutch medical device company is introducing MUSA, the world’s first clinically available CE-certified microsurgical robot. We will maximize microsurgical perf...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CPP2021-008711
Robot láser para cirugía mínimamente invasiva de columna
1K€
Cerrado
M.I.L.A.N.O. Robot
Transforming everyday surgery into a painless and scarless e...
4M€
Cerrado
DPI2008-06857-C02-01
ESTUDIO Y DESARROLLO DE ESTRATEGIAS DE COOPERACION MULTIROBO...
242K€
Cerrado
DPI2013-47196-C3-2-R
INTERFAZ DE SUPERVISION Y CONTROL COOPERATIVO DEL CAMPO OPER...
109K€
Cerrado
DPI2010-21126-C03-01
PLATAFORMA ROBOTIZADA PARA LA ASISTENCIA EN TECNICAS NOTES/S...
327K€
Cerrado
MagFlow
Introducing the first fully flow conveyed and magnetically s...
150K€
Cerrado
Información proyecto MEETMUSA
Duración del proyecto: 23 meses
Fecha Inicio: 2022-05-03
Fecha Fin: 2024-04-30
Líder del proyecto
MICROSURE BV
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
3M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The revolution in microsurgery is here. Microsure, a highly innovative Dutch medical device company is introducing MUSA, the world’s first clinically available CE-certified microsurgical robot. We will maximize microsurgical performance by offering superhuman precision and comfort through robotic assistance in pursuit of excellence for both patients and health providers. The MUSA robot is highly efficient thereby reducing costs and improving access to microsurgical procedures. With the great unmet need in microsurgery, we are convinced that the timing for market introduction of MUSA is right and the field is ready to accept and implement MUSA for better patient outcomes. In this project, we will tackle the remaining bottlenecks for succesful outroll of the product including upscaling and optimizing manufacturability, to allow for rapid market uptake of MUSA after the project. MicroSure will introduce MUSA in all parts of Europe before 2029, reaching major societal and economic impact.